Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
149.1 USD | +0.82% | +1.04% | -4.86% |
Apr. 22 | J&J: EU green light for Carvykti in multiple myeloma | CF |
Apr. 22 | Daiwa Securities Adjusts Johnson & Johnson's Price Target to $160 From $170, Maintains Outperform Rating | MT |
Financials (USD)
Sales 2024 * | 88.39B | Sales 2025 * | 90.87B | Capitalization | 359B |
---|---|---|---|---|---|
Net income 2024 * | 21.05B | Net income 2025 * | 22.24B | EV / Sales 2024 * | 3.99 x |
Net cash position 2024 * | 7B | Net cash position 2025 * | 21.07B | EV / Sales 2025 * | 3.72 x |
P/E ratio 2024 * |
17.1
x | P/E ratio 2025 * |
16
x | Employees | 131,900 |
Yield 2024 * |
3.24% | Yield 2025 * |
3.38% | Free-Float | 77.1% |
Latest transcript on Johnson & Johnson
1 day | +0.04% | ||
1 week | +1.04% | ||
Current month | -5.73% | ||
1 month | -3.94% | ||
3 months | -8.22% | ||
6 months | -2.54% | ||
Current year | -4.86% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 88-12-31 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 97-12-31 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 19-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 19-04-24 |
D. Davis
BRD | Director/Board Member | 72 | 14-06-18 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 09-10-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.01% | 215 M€ | +12.92% | - | |
12.91% | 18 M€ | +2.56% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 149.1 | +0.82% | 10,118,694 |
24-04-19 | 147.9 | +1.49% | 9,750,751 |
24-04-18 | 145.7 | +0.67% | 9,887,704 |
24-04-17 | 144.8 | +0.22% | 9,378,059 |
24-04-16 | 144.4 | -2.13% | 12,774,859 |
Delayed Quote Nyse, April 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.86% | 359B | |
+25.46% | 659B | |
+25.38% | 557B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.13% | 215B | |
+2.93% | 210B | |
-7.65% | 200B | |
-8.79% | 149B | |
-5.59% | 146B |
- Stock Market
- Equities
- JNJ Stock